Cargando…
Serum Myostatin Is Reduced in Individuals with Metabolic Syndrome
AIMS: Myostatin is a negative regulator of skeletal muscle mass and may also modulate energy metabolism secondarily. We aim to investigate the relationship between serum myostatin and the metabolic variables in diabetic (DM) and non-diabetic subjects. MATERIALS AND METHODS: A cross-sectional study r...
Autores principales: | Han, Der-Sheng, Chu-Su, Yu, Chiang, Chih-Kang, Tseng, Fen-Yu, Tseng, Ping-Huei, Chen, Chi-Ling, Wu, Kwan-Dun, Yang, Wei-Shiung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177900/ https://www.ncbi.nlm.nih.gov/pubmed/25254550 http://dx.doi.org/10.1371/journal.pone.0108230 |
Ejemplares similares
-
The serum level of a novel lipogenic protein Spot 14 was reduced in metabolic syndrome
por: Chen, Yen-Ting, et al.
Publicado: (2019) -
Human serum RNase-L level is inversely associated with metabolic syndrome and age
por: Wang, Yi-Ting, et al.
Publicado: (2017) -
Serum reference value of two potential doping candidates—myostatin and insulin-like growth factor-I in the healthy young male
por: Han, Der-Sheng, et al.
Publicado: (2017) -
Serum Spot 14 concentration is negatively associated with thyroid-stimulating hormone level
por: Chen, Yen-Ting, et al.
Publicado: (2016) -
Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism
por: Tseng, Fen-Yu, et al.
Publicado: (2016)